Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Seagen Inc (NQ: SGEN )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Dec 13, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Seagen Inc

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
This High-Yield Dividend Stock Is a Proven Wealth Creator
This heavily sold-off pharma stock is a bargain. 
Via The Motley Fool
Looking At Seagen's Recent Unusual Options Activity
Via Benzinga
The 7 Most Undervalued Long-Term Stocks to Buy: October 2023
Equities remain under pressure, but if you’re looking to be a contrarian investor, it’s a good time to look for undervalued long-term stocks. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
(SGEN) - Analyzing Seagen's Short Interest
Via Benzinga
Here's How Much $1000 Invested In Seagen 5 Years Ago Would Be Worth Today
Via Benzinga
How Is The Market Feeling About Seagen?
Via Benzinga
Earnings Scheduled For November 1, 2023
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion. 
Via Benzinga
Earnings Outlook For Seagen
Via Benzinga
How This New Merck Regimen Could 'Rewrite Textbooks' In Cancer Treatment — And Bolster 4 Stocks
The companies studied a combination of Keytruda and Padcev in bladder cancer patients. 
Via Investor's Business Daily
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?
The venerable pharmaceutical companies' shares have slumped this year. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Merck's Best Selling Cancer Drug Meets One Goal In Late-Stage Bladder Cancer Study
Merck & Co Inc (NYSE: MRK) announced that the Phase 3 AMBASSADOR (A031501) trial (KEYNOTE-123) evaluating Keytruda met one of its dual primary endpoints of disease-free survival for the adjuvant... 
Via Benzinga
2 High-Yield Dividend Stocks to Buy in October
These two high-yield dividend stocks are too cheap to ignore. 
Via The Motley Fool
If You Invested $100 In This Stock 20 Years Ago, You Would Have $3,400 Today
Via Benzinga
Seagen Unusual Options Activity
Via Benzinga
(SGEN) - Analyzing Seagen's Short Interest
Via Benzinga
3 Top Stocks to Buy in October and Hold Forever
Check out these three blue chip buys playing crucial roles in America's $6 trillion healthcare opportunity. 
Via The Motley Fool
Don’t Miss the Boom: 3 Pharma Stocks Set to Explode Higher
These pharma stocks could boom in the coming years, riding their diversified pipelines with massive addressable markets higher. 
Via InvestorPlace
September's Shakeout: S&P 500, Nasdaq 100 See Just 13% Of Stocks Above 50-Day Average
The September market downturn is spreading like wildfire across various sectors, with only a handful of stocks managing to maintain the positive trend seen in recent months. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Seagen Stock Trading Higher Today?
Seagen Inc (NASDAQ: SGEN) and Astellas Pharma Inc (OTC: ALPMF) (OTC:  
Via Benzinga
Seagen Pops After Scoring A 'Must-Win' For Its $43 Billion Takeover By Pfizer
The companies tested a key combination in patients with previously untreated bladder cancer. 
Via Investor's Business Daily
Check Out What Whales Are Doing With SGEN
Via Benzinga
Check Out What Whales Are Doing With SGEN
Via Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $16,000 Today
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Why Shares of Iovance Biotherapeutics Dropped Thursday
The biotech stock's lead therapy is looking at some competition. 
Via The Motley Fool
The 3 Most Undervalued Pharma Stocks to Buy in September 2023
Investing in pharmaceutical industry always carries risk, but several pharma stocks have an attractive risk/reward valuation right now. 
Via InvestorPlace
Why Is Cancer Focused Nurix Therapeutics Stock Trading Higher Today?
Nurix Therapeutics Inc (NASDAQ: NRIX) has entered into a multi-year, multi-target strategic collaboration agreement with Seagen Inc (NASDAQ: SGEN) to advance a new class of medicines called... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.